Corton Capital’s Labcorp LH Stock Holding History

Corton Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,392	Closed	-$282K	–	357
2022 Q4	$282K	Buy	+1,392	New	+$272K	0.23%	139
2022 Q3	–	Sell	-1,069	Closed	-$215K	–	326
2022 Q2	$215K	Sell	1,069 -895	-46%	-$191K	0.2%	214
2022 Q1	$445K	Buy	+1,964	New	+$462K	0.19%	141

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Corton Capital's LH Position: Q1 2023 in Review

Corton Capital sold out of Labcorp (LH) in Q1 2023, closing a stake of 1,392 shares — an estimated $282K sold.

Corton Capital first reported a position in LH in Q1 2022 and held it in 3 quarters. The position peaked at $445K in Q1 2022. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

Corton Capital reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
Corton Capital sold 1,392 Labcorp shares in Q1 2023, an estimated $282K.
Corton Capital first reported a position in Labcorp in Q1 2022 and held it in 3 quarters.
Corton Capital's Labcorp position peaked at $445K in Q1 2022.
940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Corton Capital's 13F filing for Q1 2023, filed 15 May 2023.